Dr. Rahul Madhav Kale, MD

Dr. Kale practices at Paloma Medical Group Inc in San Juan Capistrano, California.

Dr. Kale's NPI, 1447330915, was assigned on October 17, 2006. Dr. Kale graduated from Universidad Autonoma de Guadalajara in 2000. Dr. Kale's California license number on file is A86820.

Dr. Kale's primary practice is Paloma Medical Group Inc, at 30230 Rancho Viejo Rd, San Juan Capistrano, CA 92675 in Orange County. The practice phone is (949) 443-4303.

Dr. Kale's primary practice is Paloma Medical Group Inc in San Juan Capistrano, California. Dr. Kale is also affiliated with UCI Health - Orange. The medical group on file is UCI Health Physicians. Dmand AI also links Dr. Kale to 2 more hospitals, 4 group practices and clinics, 3 medical groups, 1 hospice and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kale practices, 9 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Kale's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Kale is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Kale has a license on file in California.

Dmand AI lists asthma, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, pulmonary fibrosis, sleep apnea and tobacco use among the conditions Dr. Kale treats.

CMS data shows 2,878 Medicare services from Dr. Kale across 17 procedure codes in 2024, for 367 Medicare patients. Medicare paid $351,026 for them.

CMS counts 367 Medicare patients who saw Dr. Kale in 2024. The largest group is 75 to 84, with 133 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 41% are also on Medicaid. Their average risk score is 3.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kale's median patient age at 73, with 50% women.

In 2024, Dr. Kale wrote 1,215 Medicare Part D claims for 126 patients. 66% of them were for generic drugs. CMS names the drug for 798 of them, across 32 drugs with 11 or more claims each, at $108,308 in total drug cost. In 2023, CMS named 428 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kale for performance year 2024, reported through an alternative payment model (APM). Dr. Kale accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 412 general payments to Dr. Kale from 58 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. GlaxoSmithKline, LLC. paid the most, $1,314.

Dr. Kale graduated from Universidad Autonoma de Guadalajara in 2000.

Dr. Kale is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.